Thomas Rice, Pauline Rosenau, Lynn Y Unruh, Andrew J Barnes
{"title":"United States: Health System Review.","authors":"Thomas Rice, Pauline Rosenau, Lynn Y Unruh, Andrew J Barnes","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This analysis of the US health system reviews the developments in organization and governance, health financing, healthcare provision, health reforms and health system performance. The US health system has both considerable strengths and notable weaknesses. It has a large and well-trained health workforce and a wide range of high-quality medical specialists, as well as secondary and tertiary institutions, a robust health sector research programme and, for selected services, among the best medical outcomes in the world. But it also suffers from incomplete coverage of its citizenry, health expenditure levels per person far exceeding all other countries, poor measures on many objective and subjective measures of quality and outcomes, and an unequal distribution of resources and outcomes across the country and among different population groups. It is difficult to determine the extent to which deficiencies are health-system related, though it is clear that at least some of the problems are a result of poor access to care. The adoption of the Affordable Care Act in 2010 resulted in greatly improved coverage through subsidies for the uninsured to purchase private insurance, expanded eligibility for Medicaid (in some states), and greater protection for insured persons. Furthermore, primary care and public health received increased funding, and quality and expenditures were addressed through a range of measures such as financial rewards for providing higher-value care. At the same time, a change in political administration resulted in subsequent efforts to scale back the legislation. Many key issues remain, including further reducing the number of uninsured people, alleviating some of the burdensome patient cost-sharing requirements, and considering some new cost-containment methods such as allowing the government to negotiate drug prices with pharmaceutical manufacturers. The direction of future health policy will almost certainly depend on which political party is in power.</p>","PeriodicalId":38995,"journal":{"name":"Health systems in transition","volume":"22 4","pages":"1-441"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health systems in transition","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
This analysis of the US health system reviews the developments in organization and governance, health financing, healthcare provision, health reforms and health system performance. The US health system has both considerable strengths and notable weaknesses. It has a large and well-trained health workforce and a wide range of high-quality medical specialists, as well as secondary and tertiary institutions, a robust health sector research programme and, for selected services, among the best medical outcomes in the world. But it also suffers from incomplete coverage of its citizenry, health expenditure levels per person far exceeding all other countries, poor measures on many objective and subjective measures of quality and outcomes, and an unequal distribution of resources and outcomes across the country and among different population groups. It is difficult to determine the extent to which deficiencies are health-system related, though it is clear that at least some of the problems are a result of poor access to care. The adoption of the Affordable Care Act in 2010 resulted in greatly improved coverage through subsidies for the uninsured to purchase private insurance, expanded eligibility for Medicaid (in some states), and greater protection for insured persons. Furthermore, primary care and public health received increased funding, and quality and expenditures were addressed through a range of measures such as financial rewards for providing higher-value care. At the same time, a change in political administration resulted in subsequent efforts to scale back the legislation. Many key issues remain, including further reducing the number of uninsured people, alleviating some of the burdensome patient cost-sharing requirements, and considering some new cost-containment methods such as allowing the government to negotiate drug prices with pharmaceutical manufacturers. The direction of future health policy will almost certainly depend on which political party is in power.
这份对美国卫生系统的分析回顾了组织和治理、卫生融资、医疗保健提供、卫生改革和卫生系统绩效方面的发展。美国的卫生系统既有相当大的优势,也有明显的弱点。它拥有一支庞大而训练有素的卫生工作队伍和各种高质量的医学专家,以及二级和三级机构,一个强有力的卫生部门研究方案,在某些服务方面,是世界上最好的医疗成果之一。但它也面临着公民覆盖面不全、人均卫生支出水平远远超过所有其他国家、许多客观和主观的质量和结果衡量指标不佳、以及全国各地和不同人口群体之间资源和结果分配不平等等问题。很难确定缺陷在多大程度上与卫生系统有关,尽管很明显,至少有一些问题是难以获得保健的结果。2010年通过的《平价医疗法案》(Affordable Care Act)通过为未参保者购买私人保险提供补贴,扩大了医疗补助计划(在一些州)的资格,并为参保人员提供了更大的保护,大大提高了覆盖面。此外,初级保健和公共卫生获得了更多的资金,并通过提供高价值保健的财政奖励等一系列措施解决了质量和支出问题。与此同时,政治管理的变化导致了后来缩减立法的努力。许多关键问题仍然存在,包括进一步减少没有保险的人数,减轻一些繁重的病人费用分摊要求,并考虑一些新的成本控制方法,例如允许政府与制药商谈判药品价格。未来医疗政策的方向几乎肯定取决于哪个政党执政。